These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 10609004)

  • 1. Malformative and neoplastic glioneuronal lesions in patients with chronic pharmacoresistant epilepsies.
    Wolf HK; Wiestler OD
    Adv Neurol; 1999; 81():69-79. PubMed ID: 10609004
    [No Abstract]   [Full Text] [Related]  

  • 2. Expression of CD34 as a novel marker for glioneuronal lesions associated with chronic intractable epilepsy.
    Deb P; Sharma MC; Tripathi M; Sarat Chandra P; Gupta A; Sarkar C
    Neuropathol Appl Neurobiol; 2006 Oct; 32(5):461-8. PubMed ID: 16972880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Neuropathology of the glioneuronal lesions of the brain associated with pharmacoresistant epilepsy].
    Zámecník J
    Cesk Patol; 2007 Jul; 43(3):79-85. PubMed ID: 17821834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glioneuronal malformative lesions and dysembryoplastic neuroepithelial tumors in patients with chronic pharmacoresistant epilepsies.
    Wolf HK; Wellmer J; Müller MB; Wiestler OD; Hufnagel A; Pietsch T
    J Neuropathol Exp Neurol; 1995 Mar; 54(2):245-54. PubMed ID: 7876892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Histopathology of 110 cortical resections for drug-resistant epilepsy].
    Vital A; Rivel J; Loiseau H; Marchal C; Rougier A; Vital C
    Rev Neurol (Paris); 1994; 150(1):33-8. PubMed ID: 7801038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurochemical profile of glioneuronal lesions from patients with pharmacoresistant focal epilepsies.
    Wolf HK; Birkholz T; Wellmer J; Blümcke I; Pietsch T; Wiestler OD
    J Neuropathol Exp Neurol; 1995 Sep; 54(5):689-97. PubMed ID: 7666058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular neuropathology of epilepsy-associated glioneuronal malformations.
    Becker AJ; Blümcke I; Urbach H; Hans V; Majores M
    J Neuropathol Exp Neurol; 2006 Feb; 65(2):99-108. PubMed ID: 16462201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutational and immunohistochemical analysis of ezrin-, radixin-, moesin (ERM) molecules in epilepsy-associated glioneuronal lesions.
    Majores M; Schick V; Engels G; Fassunke J; Elger CE; Schramm J; Blümcke I; Becker AJ
    Acta Neuropathol; 2005 Dec; 110(6):537-46. PubMed ID: 16231158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathologic aspects of cortical dysplasia in patients with pharmacoresistant epilepsies.
    Bornemann A; Schulemann H; Buchfelder M; Stefan H
    Adv Neurol; 1999; 81():323-7. PubMed ID: 10609029
    [No Abstract]   [Full Text] [Related]  

  • 10. Papillary glioneuronal tumor--a new tumor entity.
    Broholm H; Madsen FF; Wagner AA; Laursen H
    Clin Neuropathol; 2002; 21(1):1-4. PubMed ID: 11846038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pleomorphic xanthoastrocytoma derived from glioneuronal malformation in a child with intractable epilepsy.
    Ramelli GP; von der Weid N; Remonda L; Mariani L; Weis J
    J Child Neurol; 2000 Apr; 15(4):270-2. PubMed ID: 10805198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations of phosphatidylinositol 3-kinase pathway components in epilepsy-associated glioneuronal lesions.
    Schick V; Majores M; Koch A; Elger CE; Schramm J; Urbach H; Becker AJ
    Epilepsia; 2007; 48 Suppl 5():65-73. PubMed ID: 17910583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pathology of intractable epilepsy with regard to surgical treatment].
    Arai N
    Seishin Shinkeigaku Zasshi; 2001; 103(3):299-309. PubMed ID: 11383148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Disorders of perigliomatous neuroglia].
    Aranovich J
    Prensa Med Argent; 1971 Mar; 58(4):188-92. PubMed ID: 4326263
    [No Abstract]   [Full Text] [Related]  

  • 15. The IL-1beta system in epilepsy-associated malformations of cortical development.
    Ravizza T; Boer K; Redeker S; Spliet WG; van Rijen PC; Troost D; Vezzani A; Aronica E
    Neurobiol Dis; 2006 Oct; 24(1):128-43. PubMed ID: 16860990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Refractory partial epilepsy: morphological imaging in children].
    Raybaud C
    Rev Neurol (Paris); 2004 Jun; 160 Spec No 1():5S106-16. PubMed ID: 15331956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution, characterization and clinical significance of microglia in glioneuronal tumours from patients with chronic intractable epilepsy.
    Aronica E; Gorter JA; Redeker S; Ramkema M; Spliet WG; van Rijen PC; Leenstra S; Troost D
    Neuropathol Appl Neurobiol; 2005 Jun; 31(3):280-91. PubMed ID: 15885065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Contribution of MRI to the exploration of partial refractory epilepsy].
    Dupont S; Baulac M
    Rev Neurol (Paris); 2004 Jun; 160 Spec No 1():5S91-7. PubMed ID: 15331954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug resistance and hippocampal damage after delayed treatment of pilocarpine-induced epilepsy in the rat.
    Chakir A; Fabene PF; Ouazzani R; Bentivoglio M
    Brain Res Bull; 2006 Dec; 71(1-3):127-38. PubMed ID: 17113938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Mixed neuroglial tumor: description of a case].
    Pistolesi S; Castagna M; Vannozzi R; Cantini R; Pingitore R
    Pathologica; 2001 Feb; 93(1):57-60. PubMed ID: 11294021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.